265. Hodgkin's Disease; T Cell Disorders Flashcards

1
Q

What are the 4 markers of normal mature T Cells?

A

CD 2, 3, 5, 7 (CD3 most important)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Peripheral T Cell/NK Cell Lymphoma (GENERAL)

  • epi
  • tumor behavior
A

More common in ASIA

Usually AGGRESSIVE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Adult T Cell Leukemia/Lymphoma (ATLL)

  • etiology
  • epi, demo
  • CP
  • prognosis
  • morph (blood smear)
  • cell of origin
  • marker
A

E: HTLV-1 (Human T-cell Lymphoma Virus)
Epi: Japan, Caribbean, Central Africa
Demo: Adults only (avg 58yo) - exposed to virus early in life
CP: VaRiEs - leukemic, lymphomatous, smoldering
Prognosis: AGGRESSIVE, POOR (<10% survive 5 years)
Morph: lymphocytes with FLOWER-SHAPED NUCLEI
Cell of origin: CD4+ T Cell
Marker: loss of CD7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Anaplastic Large Cell Lymphoma (ALCL)

  • epi (2 subtypes)
  • genetics
  • prognosis (2 subtypes)
  • morph (blood smear)
  • marker
A

Epi: ALK+ ALCL more common in PEDIATRICS; ALK- ALCL more common in ELDERLY
Gene: ALK+ ALCL has t(2;5) or other translocation (ALK on Ch2)
Prognosis: ALK+ is FAVORABLE, ALK- is POOR
Morph: HALLMARK CELLS (large cells, horseshoe nuclei)
IHC: CD30+ (all types), ALK+ (only subtype)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Extranodal NK/T Cell Lymphoma, Nasal Type

  • etiology
  • site of involvement
  • prognosis
  • markers
A

MOST ARE NK
Eti: EBV+
Sites: nasal cavity most common (can occur elsewhere)
Prognosis: POOR
IHC: NK phenotype (surface CD3-, cytoplasmic CD3+, CD56+, cytotoxic molecules+), EBV+
- NK cells therefore are stain CD3+ but flow cytometry CD3-!!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mycosis Fungoides and Sezary Syndrome

  • epi
  • morph (blood smear)
  • cell of origin
  • marker
  • prognosis
  • triad of Sezary Syndrome
A

MF

  • epi: most common primary cutaneous T Cell Lymphoma
  • morph: CEREBRIFORM nuclei
  • cell: CD4+ T cells
  • IHC: CD7-
  • Prognosis: INDOLENT

Sezary

  • Erythroderma
  • Generalized Lymphadenopathy
  • Peripheral blood with CERIBRIFORM (convoluted) nuclei (Sezary cells - neoplastic)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Hodgkin Lymphoma

  • two major WHO categories of HL
  • features/prognosis of first category
  • features of second category (demo, markers, morph)
  • most common subtype of second category (CP)
A
  1. Nodular Lymphocyte Predominant HL (5% pts)
    - B Cell Neoplasm
    - GOOD prognosis
  2. Classical HL (95% pts)
    - demo: BIMODAL age (younger and older adults)
    - markers: CD3-, CD20- (lose B cell), CD30+, CD15+ (KEY), PAX5+ (retains B cell transcription factor)
    - morph: REED-STERNBERG CELLS (large cell, bilobed nuclei, prominent nucleoli)

Nodular Sclerosis Classical HL
- 80% involve mediastinum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly